Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5229)
All Articles published online
|
Dec 21, 2009 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zlobec I, Lugli A. Invasive front of colorectal cancer: Dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 2009; 15(47): 5898-5906 [PMID: 20014453 DOI: 10.3748/wjg.15.5898] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i47/5898.htm |
| Number | Citing Articles |
| 1 |
Feiqing Wang, Jianing Zhao, Chike Zhang, Bo Yang, Tingting Tian, Mengxian Tian, Na Meng, Wei Xie, Guangyang Liu, Xiaodong Zhu, Min Su, Zhixu He, Yang Liu, Dongxin Tang, Yanju Li. Effect of microserum environment stimulation on extraction and biological function of colorectal cancer stem cells. Discover Oncology 2023; 14(1) doi: 10.1007/s12672-023-00779-z
|
| 2 |
Tuulia Avoranta, Jari Sundström, Eija Korkeila, Kari Syrjänen, Seppo Pyrhönen, Jukka Laine. The expression and distribution of group IIA phospholipase A2 in human colorectal tumours. Virchows Archiv 2010; 457(6): 659 doi: 10.1007/s00428-010-0992-7
|
| 3 |
Tae-Hwa Baek, Dong-Wook Kang, Joo-Heon Kim, Hyun-Jin Son. Gland Attenuation, a Novel Morphological Feature of Colorectal Cancer: Evidence for an Epithelial-Mesenchymal Transition. Annals of Coloproctology 2018; 34(4): 187 doi: 10.3393/ac.2017.12.02
|
| 4 |
Adam R. Markowski, Anna J. Markowska, Wiktoria Ustymowicz, Anna Pryczynicz, Katarzyna Guzińska-Ustymowicz. Simultaneous analysis of tumor-infiltrating immune cells density, tumor budding status, and presence of lymphoid follicles in CRC tissue. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-26225-8
|
| 5 |
Tetsuhiko Taira, Genichiro Ishii, Kanji Nagai, Kiyotaka Yoh, Yusuke Takahashi, Yuki Matsumura, Motohiro Kojima, Hironobu Ohmatsu, Koichi Goto, Seiji Niho, Hiroshi Takashima, Hiromasa Inoue, Yuichiro Ohe, Atsushi Ochiai. Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung. Lung Cancer 2012; 76(3): 423 doi: 10.1016/j.lungcan.2011.11.010
|
| 6 |
Tsuyoshi Konishi, Yoshifumi Shimada, Lik Hang Lee, Marcela S. Cavalcanti, Meier Hsu, Jesse Joshua Smith, Garrett M. Nash, Larissa K. Temple, José G. Guillem, Philip B. Paty, Julio Garcia-Aguilar, Efsevia Vakiani, Mithat Gonen, Jinru Shia, Martin R. Weiser. Poorly Differentiated Clusters Predict Colon Cancer Recurrence. American Journal of Surgical Pathology 2018; 42(6): 705 doi: 10.1097/PAS.0000000000001059
|
| 7 |
George S. Karagiannis, Ann Treacy, David Messenger, Andrea Grin, Richard Kirsch, Robert H. Riddell, Eleftherios P. Diamandis. Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts. Molecular Oncology 2014; 8(7): 1240 doi: 10.1016/j.molonc.2014.04.004
|
| 8 |
ZHAO-HUA GAO, CHONG LU, MEI-XIAN WANG, YI HAN, LI-JUAN GUO. Differential β-catenin expression levels are associated with morphological features and prognosis of colorectal cancer. Oncology Letters 2014; 8(5): 2069 doi: 10.3892/ol.2014.2433
|
| 9 |
Leslie Michaels, Sava Soucek. Origin and growth of otosclerosis. Acta Oto-Laryngologica 2011; 131(5): 460 doi: 10.3109/00016489.2010.532156
|
| 10 |
Ana P. Cardoso, Marta L. Pinto, Ana T. Pinto, Marta T. Pinto, Cátia Monteiro, Marta I. Oliveira, Susana G. Santos, João B. Relvas, Raquel Seruca, Alberto Mantovani, Marc Mareel, Mário A. Barbosa, Maria J. Oliveira. Matrix metalloproteases as maestros for the dual role of LPS- and IL-10-stimulated macrophages in cancer cell behaviour. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1466-8
|
| 11 |
Eva Karamitopoulou, Inti Zlobec, Viktor Hendrik Koelzer, Rupert Langer, Heather Dawson, Alessandro Lugli. Tumour border configuration in colorectal cancer: proposal for an alternative scoring system based on the percentage of infiltrating margin. Histopathology 2015; 67(4): 464 doi: 10.1111/his.12665
|
| 12 |
Fernando Macias-Garcia, Catuxa Celeiro-Muñoz, Lucia Lesquereux-Martinez, Francisco Gude-Sampedro, Laura Uribarri-Gonzalez, Ihab Abdulkader, Ana Alvarez-Castro, J. Enrique Dominguez-Muñoz. A clinical model for predicting lymph node metastasis in submucosal invasive (T1) colorectal cancer. International Journal of Colorectal Disease 2015; 30(6): 761 doi: 10.1007/s00384-015-2164-3
|
| 13 |
Koichi Sato, Takeshi Uehara, Tomoyuki Nakajima, Mai Iwaya, Yusuke Miyagawa, Takayuki Watanabe, Hiroyoshi Ota. Inverse correlation between PD-L1 expression and LGR5 expression in tumor budding of stage II/III colorectal cancer. Annals of Diagnostic Pathology 2021; 52: 151739 doi: 10.1016/j.anndiagpath.2021.151739
|
| 14 |
Anca Haisan, Radu Rogojanu, Camelia Croitoru, Daniela Jitaru, Cristina Tarniceriu, Mihai Danciu, Eugen Carasevici. Digital Microscopy Assessment of Angiogenesis in Different Breast Cancer Compartments. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/286902
|
| 15 |
Hyo Seon Ryu, Jong Lyul Lee, Chan Wook Kim, Yong Sik Yoon, In Ja Park, Seok-Byung Lim, Chang Sik Yu, Ji Hun Kim, Jin Cheon Kim. Correlative Significance of Tumor Regression Grade and ypT Category in Patients Undergoing Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer. Clinical Colorectal Cancer 2022; 21(3): 212 doi: 10.1016/j.clcc.2022.02.001
|
| 16 |
Ausrine Nestarenkaite, Wakkas Fadhil, Allan Rasmusson, Susanti Susanti, Efthymios Hadjimichael, Aida Laurinaviciene, Mohammad Ilyas, Arvydas Laurinavicius. Immuno-Interface Score to Predict Outcome in Colorectal Cancer Independent of Microsatellite Instability Status. Cancers 2020; 12(10): 2902 doi: 10.3390/cancers12102902
|
| 17 |
Pantea Pour Farid, Markus Eckstein, Susanne Merkel, Robert Grützmann, Arndt Hartmann, Volker Bruns, Michaela Benz, Regine Schneider-Stock, Carol I. Geppert. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes. International Journal of Molecular Sciences 2021; 22(23): 13108 doi: 10.3390/ijms222313108
|
| 18 |
Eike Burandt, Niclas C. Blessin, Ann-Christin Rolschewski, Florian Lutz, Tim Mandelkow, Cheng Yang, Elena Bady, Viktor Reiswich, Ronald Simon, Guido Sauter, Sven Mahner, Nikolaus de Gregorio, Rüdiger Klapdor, Matthias Kalder, Elena I. Braicu, Sophie Fürst, Maximilian Klar, Hans-Georg Strauß, Katharina Prieske, Linn Wölber. T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer. Cancers 2022; 14(17): 4246 doi: 10.3390/cancers14174246
|
| 19 |
C H Richards, K M Flegg, C SD Roxburgh, J J Going, Z Mohammed, P G Horgan, D C McMillan. The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer. British Journal of Cancer 2012; 106(12): 2010 doi: 10.1038/bjc.2012.211
|
| 20 |
Heather Dawson, Alessandro Lugli. Molecular and Pathogenetic Aspects of Tumor Budding in Colorectal Cancer. Frontiers in Medicine 2015; 2 doi: 10.3389/fmed.2015.00011
|
| 21 |
Sofia B. Gustafsson, Richard Palmqvist, Maria L. Henriksson, Anna M. Dahlin, Sofia Edin, Stig O. P. Jacobsson, Åke Öberg, Christopher J. Fowler, Joseph Alan Bauer. High Tumour Cannabinoid CB1 Receptor Immunoreactivity Negatively Impacts Disease-Specific Survival in Stage II Microsatellite Stable Colorectal Cancer. PLoS ONE 2011; 6(8): e23003 doi: 10.1371/journal.pone.0023003
|
| 22 |
S. El-Gendi, A. Al-Gendi. Assessment of tumor budding in colorectal carcinoma: Correlation with β-catenin nuclear expression. Journal of the Egyptian National Cancer Institute 2011; 23(1): 1 doi: 10.1016/j.jnci.2011.07.001
|
| 23 |
Takanori Hiraide, Koji Ikegami, Takanori Sakaguchi, Yoshifumi Morita, Takahiro Hayasaka, Noritaka Masaki, Michihiko Waki, Eiji Sugiyama, Satoru Shinriki, Makoto Takeda, Yasushi Shibasaki, Shinichiro Miyazaki, Hirotoshi Kikuchi, Hiroaki Okuyama, Masahiro Inoue, Mitsutoshi Setou, Hiroyuki Konno. Accumulation of arachidonic acid-containing phosphatidylinositol at the outer edge of colorectal cancer. Scientific Reports 2016; 6(1) doi: 10.1038/srep29935
|
| 24 |
Chandra Kirana, Hongjun Shi, Emma Laing, Kylie Hood, Rose Miller, Peter Bethwaite, John Keating, T. William Jordan, Mark Hayes, Richard Stubbs. Cathepsin D Expression in Colorectal Cancer: From Proteomic Discovery through Validation Using Western Blotting, Immunohistochemistry, and Tissue Microarrays. International Journal of Proteomics 2012; 2012: 1 doi: 10.1155/2012/245819
|
| 25 |
Jelena Ivanovska, Inti Zlobec, Stefan Forster, Eva Karamitopoulou, Heather Dawson, Viktor Hendrik Koelzer, Abbas Agaimy, Fabian Garreis, Stephan Söder, William Laqua, Alessandro Lugli, Arndt Hartmann, Tilman T. Rau, Regine Schneider-Stock. DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells. Oncotarget 2015; 6(34): 36774 doi: 10.18632/oncotarget.4908
|
| 26 |
Ana Pavlič, Kristian Urh, Emanuela Boštjančič, Nina Zidar. Analyzing the invasive front of colorectal cancer – By punching tissue block or laser capture microdissection?. Pathology - Research and Practice 2023; 248: 154727 doi: 10.1016/j.prp.2023.154727
|
| 27 |
Yulin Liu, Yiting Wang, Su Yao, Changhong Liang, Qian Li, Zaiyi Liu, Yaxi Zhu, Yanfen Cui, Ke Zhao. Development and validation of a scoring system incorporating tumor growth pattern and perineural invasion for risk stratification in colorectal cancer. Journal of Investigative Medicine 2023; 71(6): 674 doi: 10.1177/10815589231167359
|
| 28 |
Si Li, Fangying Xu, Hui Li, Jing Zhang, Anjing Zhong, Bin Huang, Maode Lai. S100A8+stroma cells predict a good prognosis and inhibit aggressiveness in colorectal carcinoma. OncoImmunology 2017; 6(1): e1260213 doi: 10.1080/2162402X.2016.1260213
|
| 29 |
Leslie Michaels, Sava Soucek. Atypical mature bone in the otosclerotic otic capsule as the differentiated zone of an invasive osseous neoplasm. Acta Oto-Laryngologica 2014; 134(2): 118 doi: 10.3109/00016489.2013.849386
|
| 30 |
Yujuan Zhou, Longzheng Xia, Heran Wang, Linda Oyang, Min Su, Qiang Liu, Jingguan Lin, Shiming Tan, Yutong Tian, Qianjin Liao, Deliang Cao. Cancer stem cells in progression of colorectal cancer. Oncotarget 2018; 9(70): 33403 doi: 10.18632/oncotarget.23607
|
| 31 |
Kyoung-Ok Hong, Kyu-Young Oh, Wui-Jung Shin, Hye-Jung Yoon, Jae-Il Lee, Seong-Doo Hong. Tumor budding is associated with poor prognosis of oral squamous cell carcinoma and histologically represents an epithelial-mesenchymal transition process. Human Pathology 2018; 80: 123 doi: 10.1016/j.humpath.2018.06.012
|
| 32 |
Kirk J. Levins, S. Prendeville, S. Conlon, D. J. Buggy. The effect of anesthetic technique on µ-opioid receptor expression and immune cell infiltration in breast cancer. Journal of Anesthesia 2018; 32(6): 792 doi: 10.1007/s00540-018-2554-0
|
| 33 |
Teppei Morikawa, Aya Kuchiba, Zhi Rong Qian, Mari Mino-Kenudson, Jason L. Hornick, Mai Yamauchi, Yu Imamura, Xiaoyun Liao, Reiko Nishihara, Jeffrey A. Meyerhardt, Charles S. Fuchs, Shuji Ogino. Prognostic Significance and Molecular Associations of Tumor Growth Pattern in Colorectal Cancer. Annals of Surgical Oncology 2012; 19(6): 1944 doi: 10.1245/s10434-011-2174-5
|
| 34 |
Juha P. Väyrynen, Juha O. Vornanen, Sara Sajanti, Jan P. Böhm, Anne Tuomisto, Markus J. Mäkinen. An improved image analysis method for cell counting lends credibility to the prognostic significance of T cells in colorectal cancer. Virchows Archiv 2012; 460(5): 455 doi: 10.1007/s00428-012-1232-0
|
| 35 |
J P Väyrynen, A Tuomisto, K Klintrup, J Mäkelä, T J Karttunen, M J Mäkinen. Detailed analysis of inflammatory cell infiltration in colorectal cancer. British Journal of Cancer 2013; 109(7): 1839 doi: 10.1038/bjc.2013.508
|
| 36 |
Chie Takasu, Shoko Yamashita, Yuji Morine, Kozo Yoshikawa, Takuya Tokunaga, Masaaki Nishi, Hideya Kashihara, Toshiaki Yoshimoto, Mitsuo Shimada, Jason S. Gold. The role of the immunoescape in colorectal cancer liver metastasis. PLOS ONE 2021; 16(11): e0259940 doi: 10.1371/journal.pone.0259940
|
| 37 |
Yunrui Ye, Xiaomei Wu, Huihui Wang, Huifen Ye, Ke Zhao, Yajun Li, Minning Zhao, Qingru Hu, Xueli Zhang, Su Yao, Xin Chen, Changhong Liang, Zaiyi Liu, Xinjuan Fan, Qingling Zhang, Yanqi Huang. Artificial Intelligence-Assisted Analysis of Tumor Growth Pattern, Tumor-Infiltrating Lymphocytes, And Survival from Colorectal Cancer. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4167831
|
| 38 |
Koichi Sato, Takeshi Uehara, Mai Iwaya, Tomoyuki Nakajima, Yusuke Miyagawa, Tomoaki Suga, Hiroyoshi Ota, Eiji Tanaka. RETRACTED: Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma. Annals of Diagnostic Pathology 2019; 40: 161 doi: 10.1016/j.anndiagpath.2019.05.002
|
| 39 |
Neslihan Komut, Sibel Bektas, Emine Yildirim. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma. Annals of Diagnostic Pathology 2022; 58: 151933 doi: 10.1016/j.anndiagpath.2022.151933
|
| 40 |
Juha P. Väyrynen, Sara A. Sajanti, Kai Klintrup, Jyrki Mäkelä, Karl‐Heinz Herzig, Tuomo J. Karttunen, Anne Tuomisto, Markus J. Mäkinen. Characteristics and significance of colorectal cancer associated lymphoid reaction. International Journal of Cancer 2014; 134(9): 2126 doi: 10.1002/ijc.28533
|
| 41 |
Yoshitsugu Nakanishi, Masanori Ohara, Hiromitsu Doumen, Noriko Kimura, Takuzo Ishidate, Satoshi Kondo. Correlation Between Tumor Budding and Post‐Resection Prognosis in Patients with Invasive Squamous Cell Carcinoma of the Thoracic Esophagus. World Journal of Surgery 2011; 35(2): 349 doi: 10.1007/s00268-010-0880-y
|
| 42 |
Markus Hecht, Maike Büttner-Herold, Katharina Erlenbach-Wünsch, Marlen Haderlein, Roland Croner, Robert Grützmann, Arndt Hartmann, Rainer Fietkau, Luitpold V. Distel. PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis. European Journal of Cancer 2016; 65: 52 doi: 10.1016/j.ejca.2016.06.015
|
| 43 |
Giacomo Puppa. TNM staging system of colorectal carcinoma: surgical pathology of the seventh edition. Diagnostic Histopathology 2011; 17(6): 243 doi: 10.1016/j.mpdhp.2011.03.006
|
| 44 |
Y Backes, W H de Vos tot Nederveen Cappel, J van Bergeijk, F ter Borg, M P Schwartz, B W M Spanier, J M J Geesing, K Kessels, M Kerkhof, J N Groen, F H J Wolfhagen, T C J Seerden, N van Lelyveld, G J A Offerhaus, P D Siersema, M M Lacle, L M G Moons. Risk for Incomplete Resection after Macroscopic Radical Endoscopic Resection of T1 Colorectal Cancer: A Multicenter Cohort Study. American Journal of Gastroenterology 2017; 112(5): 785 doi: 10.1038/ajg.2017.58
|
| 45 |
José García-Solano, Pablo Conesa-Zamora, Javier Trujillo-Santos, Daniel Torres-Moreno, Markus J. Mäkinen, Miguel Pérez-Guillermo. Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma. Human Pathology 2012; 43(7): 1094 doi: 10.1016/j.humpath.2011.08.020
|
| 46 |
Gloria Romagnoli, Meike Wiedermann, Friederike Hübner, Antonia Wenners, Micaela Mathiak, Christoph Röcken, Nicolai Maass, Wolfram Klapper, Ibrahim Alkatout. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study. International Journal of Molecular Sciences 2017; 18(9): 1936 doi: 10.3390/ijms18091936
|
| 47 |
Ashna A. Kumar, Benjamin J. Buckley, Marie Ranson. The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets. Biomolecules 2022; 12(2): 152 doi: 10.3390/biom12020152
|
| 48 |
Jakob Nikolas Kather, Frank Gerrit Zöllner, Lothar R. Schad, Susanne Maria Melchers, Hans-Peter Sinn, Alexander Marx, Timo Gaiser, Cleo-Aron Weis, Domenico Ribatti. Identification of a characteristic vascular belt zone in human colorectal cancer. PLOS ONE 2017; 12(3): e0171378 doi: 10.1371/journal.pone.0171378
|
| 49 |
Yunrui Ye, Xiaomei Wu, Huihui Wang, Huifen Ye, Ke Zhao, Su Yao, Zaiyi Liu, Yaxi Zhu, Qingling Zhang, Changhong Liang. Artificial intelligence-assisted analysis for tumor-immune interaction within the invasive margin of colorectal cancer. Annals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2215541
|
| 50 |
Ana Pavlič, Emanuela Boštjančič, Rajko Kavalar, Bojan Ilijevec, Serena Bonin, Fabrizio Zanconati, Nina Zidar. Tumour budding and poorly differentiated clusters in colon cancer – different manifestations of partial epithelial–mesenchymal transition. The Journal of Pathology 2022; 258(3): 278 doi: 10.1002/path.5998
|
| 51 |
Annika Resch, Cord Langner. Risk Assessment in Early Colorectal Cancer: Histological and Molecular Markers. Digestive Diseases 2015; 33(1): 77 doi: 10.1159/000366036
|
| 52 |
Simone Bertz, Stefan Denzinger, Wolfgang Otto, Wolf F Wieland, Robert Stoehr, Ferdinand Hofstaedter, Arndt Hartmann. Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series. Histopathology 2011; 59(4): 722 doi: 10.1111/j.1365-2559.2011.03989.x
|
| 53 |
Srinivasa R. Rao, Nasullah K. Alham, Elysia Upton, Stacey McIntyre, Richard J. Bryant, Lucia Cerundolo, Emma Bowes, Stephanie Jones, Molly Browne, Ian Mills, Alastair Lamb, Ian Tomlinson, David Wedge, Lisa Browning, Korsuk Sirinukunwattana, Claire Palles, Freddie C. Hamdy, Jens Rittscher, Clare Verrill. Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration. The Journal of Molecular Diagnostics 2020; 22(5): 652 doi: 10.1016/j.jmoldx.2020.02.012
|
| 54 |
Martin R. Weiser, Meier Hsu, Philip S. Bauer, William C. Chapman, Iván A. González, Deyali Chatterjee, Deepak Lingam, Matthew G. Mutch, Ajaratu Keshinro, Jinru Shia, Efsevia Vakiani, Tsuyoshi Konishi, Yoshifumi Shimada, Zsofia Stadler, Neil H. Segal, Andrea Cercek, Leonard Saltz, Rona Yaeger, Anna Varghese, Maria Widmar, Iris H. Wei, Emmanouil P. Pappou, J. Joshua Smith, Garrett Nash, Philip Paty, Julio Garcia-Aguilar, Mithat Gonen. Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer. Journal of Clinical Oncology 2021; 39(8): 911 doi: 10.1200/JCO.20.02553
|
| 55 |
Evan L. Busch, Kathleen A. McGraw, Robert S. Sandler. The Potential for Markers of Epithelial–Mesenchymal Transition to Improve Colorectal Cancer Outcomes: A Systematic Review. Cancer Epidemiology, Biomarkers & Prevention 2014; 23(7): 1164 doi: 10.1158/1055-9965.EPI-14-0017
|
| 56 |
Guo-Jun Tong, Gui-Yang Zhang, Jian Liu, Zhao-Zheng Zheng, Yan Chen, Ping-Ping Niu, Xu-Ting Xu. Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data. World Journal of Clinical Oncology 2018; 9(7): 148-161 doi: 10.5306/wjco.v9.i7.148
|
| 57 |
Artur Mezheyeuski, Ina Hrynchyk, Mia Karlberg, Anna Portyanko, Lars Egevad, Peter Ragnhammar, David Edler, Bengt Glimelius, Arne Östman. Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer. Scientific Reports 2016; 6(1) doi: 10.1038/srep36149
|
| 58 |
Koichi Sato, Takeshi Uehara, Mai Iwaya, Tomoyuki Nakajima, Yusuke Miyagawa, Hiroyoshi Ota, Eiji Tanaka. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma. Annals of Diagnostic Pathology 2020; 48: 151587 doi: 10.1016/j.anndiagpath.2020.151587
|
| 59 |
William Sterlacci, Michael Vieth. Multidisciplinary Treatment of Colorectal Cancer. 2021; : 263 doi: 10.1007/978-3-030-58846-5_28
|
| 60 |
Sang Hoon Chun, Eun Young Kim, Jung-Sook Yoon, Hye Sung Won, Kwangil Yim, Hye Won Hwang, Soon Auck Hong, Minho Lee, Su Lim Lee, Sung-Soo Kim, Der Sheng Sun, Yoon Ho Ko. Prognostic value of noggin protein expression in patients with resected gastric cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08273-x
|
| 61 |
P. S. S. Kho, L. Jankova, C. L.-S. Fung, C. Chan, C. Clarke, B. P. C. Lin, G. Robertson, M. Molloy, P. H. Chapuis, E. L. Bokey, O. F. Dent, S. Clarke. Overexpression of protein S100A4 is independently associated with overall survival in stage C colonic cancer but only in cytoplasm at the advancing tumour front. International Journal of Colorectal Disease 2012; 27(11): 1409 doi: 10.1007/s00384-012-1469-8
|
| 62 |
Genichiro Ishii, Hiroko Hashimoto, Naho Atsumi, Ayuko Hoshino, Atsushi Ochiai. Morphophenotype of floating colonies derived from a single cancer cell has a critical impact on tumor‐forming activity. Pathology International 2013; 63(1): 29 doi: 10.1111/pin.12018
|
| 63 |
J.H. Park, C.H. Richards, D.C. McMillan, P.G. Horgan, C.S.D. Roxburgh. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer. Annals of Oncology 2014; 25(3): 644 doi: 10.1093/annonc/mdt593
|
| 64 |
Yuanyuan Zhao, Enwei Xu, Xuanqin Yang, Yong Zhang, Hong Chen, Ying Wang, Mulan Jin. Tumor infiltrative growth pattern correlates with the immune microenvironment and is an independent factor for lymph node metastasis and prognosis in stage T1 esophageal squamous cell carcinoma. Virchows Archiv 2020; 477(3): 401 doi: 10.1007/s00428-020-02801-z
|
| 65 |
Hamed Manoochehri, Shafagh Asadi, Hamid Tanzadehpanah, Mohsen Sheykhhasan, Masoud Ghorbani. CDC25A is strongly associated with colorectal cancer stem cells and poor clinical outcome of patients. Gene Reports 2021; 25: 101415 doi: 10.1016/j.genrep.2021.101415
|
| 66 |
Michela Roberto, Giulia Arrivi, Emanuela Pilozzi, Andrea Montori, Genoveffa Balducci, Paolo Mercantini, Andrea Laghi, Debora Ierinò, Martina Panebianco, Daniele Marinelli, Silverio Tomao, Paolo Marchetti, Federica Mazzuca. The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study. Cancer Management and Research 2022; : 1353 doi: 10.2147/CMAR.S342612
|
| 67 |
Tatiana S. Gerashchenko, Nikita M. Novikov, Nadezhda V. Krakhmal, Sofia Y. Zolotaryova, Marina V. Zavyalova, Nadezhda V. Cherdyntseva, Evgeny V. Denisov, Vladimir M. Perelmuter. Markers of Cancer Cell Invasion: Are They Good Enough?. Journal of Clinical Medicine 2019; 8(8): 1092 doi: 10.3390/jcm8081092
|
| 68 |
Tanya T.D. Soeratram, Hedde D. Biesma, Jacqueline M.P. Egthuijsen, Elma Meershoek-Klein Kranenbarg, Henk H. Hartgrink, Cornelis J.H. van de Velde, Aart Mookhoek, Erik van Dijk, Yongsoo Kim, Bauke Ylstra, Hanneke W.M. van Laarhoven, Nicole C.T. van Grieken. Prognostic Value of T-Cell Density in the Tumor Center and Outer Margins in Gastric Cancer. Modern Pathology 2023; 36(9): 100218 doi: 10.1016/j.modpat.2023.100218
|
| 69 |
Inti Zlobec, Alessandro Lugli. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget. Oncotarget 2010; 1(7): 651 doi: 10.18632/oncotarget.199
|
| 70 |
Zhaoyang Xu, Carlos Fernádez Moro, Danyil Kuznyecov, Béla Bozóky, Le Dong, Qianni Zhang. Tissue Region Growing for Hispathology Image Segmentation. Proceedings of the 2018 3rd International Conference on Biomedical Imaging, Signal Processing 2018; : 86 doi: 10.1145/3288200.3288213
|
| 71 |
Kwangil Yim, Won Mo Jang, Uiju Cho, Der Sheng Sun, Yosep Chong, Kyung Jin Seo. Intratumoral Budding in Pretreatment Biopsies, among Tumor Microenvironmental Components, Can Predict Prognosis and Neoadjuvant Therapy Response in Colorectal Adenocarcinoma. Medicina 2022; 58(7): 926 doi: 10.3390/medicina58070926
|
| 72 |
Yilmaz Baş, Bayram Yilmaz, Serhat Furkan Acar, İbrahim Karadağ. Programmed Cell Death Ligand 1 Expression in CD163+ Tumor-associated Macrophages in Cancer Gland Rupture Microenvironment. Applied Immunohistochemistry & Molecular Morphology 2024; 32(4): 176 doi: 10.1097/PAI.0000000000001186
|
| 73 |
Panagiotis Kampilafkos, Maria Melachrinou, Zinovia Kefalopoulou, John Lakoumentas, Georgia Sotiropoulou-Bonikou. Epigenetic Modifications in Cutaneous Malignant Melanoma. The American Journal of Dermatopathology 2015; 37(2): 138 doi: 10.1097/DAD.0b013e31828a2d54
|
| 74 |
Paul Salama, Michael Phillips, Cameron Platell, Barry Iacopetta. Low expression of Granzyme B in colorectal cancer is associated with signs of early metastastic invasion. Histopathology 2011; 59(2): 207 doi: 10.1111/j.1365-2559.2011.03915.x
|
| 75 |
Saba Sameri, Massoud Saidijam, Fatemeh Bahreini, Rezvan Najafi. Cancer Chemopreventive Activities of Silibinin on Colorectal Cancer through Regulation of E-Cadherin/β-Catenin Pathway. Nutrition and Cancer 2021; 73(8): 1389 doi: 10.1080/01635581.2020.1800764
|
| 76 |
Frank Christian Schultze, Reiner Andag, Salamah Mohammad Alwahsh, Draga Toncheva, Svilen Maslyankov, Nikolay Yaramov, Nicolas von Ahsen, Gunnar Brandhorst, Philip D. Walson, Michael Oellerich, Darinka Todorova Petrova. FoxP3 demethylation is increased in human colorectal cancer and rat cholangiocarcinoma tissue. Clinical Biochemistry 2014; 47(3): 201 doi: 10.1016/j.clinbiochem.2013.11.013
|
| 77 |
Cord Langner, Michael Vieth. Multidisciplinary Treatment of Colorectal Cancer. 2015; : 211 doi: 10.1007/978-3-319-06142-9_21
|
| 78 |
Konrad Steinestel, Jochen K. Lennerz, Stefan Eder, Klaus Kraft, Annette Arndt. Invasion pattern and histologic features of tumor aggressiveness correlate with MMR protein expression, but are independent of activating KRAS and BRAF mutations in CRC. Virchows Archiv 2014; 465(2): 155 doi: 10.1007/s00428-014-1604-8
|
| 79 |
Quyen D. Chu, Meijiao Zhou, Kaelen Medeiros, Prakash Peddi. Positive surgical margins contribute to the survival paradox between patients with stage IIB/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancer. Surgery 2016; 160(5): 1333 doi: 10.1016/j.surg.2016.05.028
|
| 80 |
Stefania Tommasi, Rosamaria Pinto, Daniela Petriella, Brunella Pilato, Rosanna Lacalamita, Daniele Santini, Francesco Zito, Giuseppe Colucci, Angelo Paradiso, Nicola Silvestris. Oncosuppressor methylation: A possible key role in colon metastatic progression. Journal of Cellular Physiology 2011; 226(7): 1934 doi: 10.1002/jcp.22524
|
| 81 |
Punnya V. Angadi, Prakash V. Patil, Kaveri Hallikeri, M. D. Mallapur, Seema Hallikerimath, Alka D. Kale. Tumor Budding Is an Independent Prognostic Factor for Prediction of Lymph Node Metastasis in Oral Squamous Cell Carcinoma. International Journal of Surgical Pathology 2015; 23(2): 102 doi: 10.1177/1066896914565022
|
| 82 |
Manish Chand, Deborah S Keller, Reza Mirnezami, Marc Bullock, Aneel Bhangu, Brendan Moran, Paris P Tekkis, Gina Brown, Alexander Mirnezami, Mariana Berho. Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data. World Journal of Gastrointestinal Oncology 2018; 10(7): 145-158 doi: 10.4251/wjgo.v10.i7.145
|
| 83 |
Aneel Bhangu, Gemma Wood, Alex Mirnezami, Ara Darzi, Paris Tekkis, Robert Goldin. Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy. Surgical Oncology 2012; 21(4): 316 doi: 10.1016/j.suronc.2012.08.003
|
| 84 |
Larissa Belov, Jerry Zhou, Richard I. Christopherson. Cell Surface Markers in Colorectal Cancer Prognosis. International Journal of Molecular Sciences 2010; 12(1): 78 doi: 10.3390/ijms12010078
|
| 85 |
K Nagata, E Shinto, M Yamadera, T Shiraishi, Y Kajiwara, K Okamoto, S Mochizuki, K Hase, Y Kishi, H Ueno. Prognostic and predictive values of tumour budding in stage IV colorectal cancer. BJS Open 2020; 4(4): 693 doi: 10.1002/bjs5.50300
|
| 86 |
Emir Bozkurt, Heiko Düssmann, Manuela Salvucci, Brenton L. Cavanagh, Sandra Van Schaeybroeck, Daniel B. Longley, Seamus J. Martin, Jochen H.M. Prehn. TRAIL signaling promotes entosis in colorectal cancer. Journal of Cell Biology 2021; 220(11) doi: 10.1083/jcb.202010030
|
| 87 |
Eva Budinská, Martina Čarnogurská, Tina Catela Ivković, Táňa Macháčková, Marie Boudná, Lucie Pifková, Ondřej Slabý, Beatrix Bencsiková, Vlad Popovici. An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1367231
|
| 88 |
Asama Khan, Hannah M. Thompson, Meier Hsu, Maria Widmar, Iris H. Wei, Emmanouil Pappou, J. Joshua Smith, Garrett M. Nash, Philip B. Paty, Julio Garcia-Aguilar, Jinru Shia, Mithat Gönen, Martin R. Weiser. Validation of a Clinical Calculator Predicting Freedom From Colon Cancer Recurrence After Surgery on the Basis of Molecular and Clinical Variables. Diseases of the Colon & Rectum 2024; 67(2): 240 doi: 10.1097/DCR.0000000000002896
|
| 89 |
Christoph Kahlert, Saleh Lahes, Praveen Radhakrishnan, Shamik Dutta, Carolin Mogler, Esther Herpel, Karsten Brand, Gunnar Steinert, Martin Schneider, Martin Mollenhauer, Christoph Reissfelder, Fee Klupp, Johannes Fritzmann, Christina Wunder, Axel Benner, Matthias Kloor, Cathrin Huth, Pietro Contin, Alexis Ulrich, Moritz Koch, Jürgen Weitz. Overexpression of ZEB2 at the Invasion Front of Colorectal Cancer Is an Independent Prognostic Marker and Regulates Tumor Invasion In Vitro
. Clinical Cancer Research 2011; 17(24): 7654 doi: 10.1158/1078-0432.CCR-10-2816
|
| 90 |
Tadakazu Ao, Yoshiki Kajiwara, Keisuke Yonemura, Eiji Shinto, Satsuki Mochizuki, Koichi Okamoto, Suefumi Aosasa, Hideki Ueno. Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases. Virchows Archiv 2019; 475(3): 341 doi: 10.1007/s00428-019-02580-2
|
| 91 |
Junqiang Liu, Chun Li, Kai Huang, Abdullah Aldanakh, Deyong Yang, Jianbo Wang, Xiuzhen Sun, Xishuang Song. A classification based on tumor-stroma ratio and tumor budding for patients with muscle-invasive bladder cancer. Expert Review of Anticancer Therapy 2022; 22(3): 323 doi: 10.1080/14737140.2022.2012158
|
| 92 |
Tae-Hwa Baek, Joo-Heon Kim, Mee-Ja Park, Hye-Kyung Lee, Hyun-Jin Son, Hyun-Ki Soon, Chang-Nam Kim, Che Myong Ko, Dong-Wook Kang. The Stromal Overexpression of Decay Accelerating Factor (DAF/CD55) Correlates with Poor Clinical Outcome in Colorectal Cancer Patients. The Korean Journal of Pathology 2011; 45(5): 445 doi: 10.4132/KoreanJPathol.2011.45.5.445
|
| 93 |
Christoph Kahlert, Tristan Lerbs, Mathieu Pecqueux, Esther Herpel, Michael Hoffmeister, Lina Jansen, Hermann Brenner, Jenny Chang‐Claude, Hendrik Bläker, Matthias Kloor, Wilfried Roth, Christian Pilarsky, Nuh N. Rahbari, Sebastian Schölch, Ulrich Bork, Christoph Reissfelder, Jürgen Weitz, Daniela Aust, Moritz Koch. Overexpression of SIX1 is an independent prognostic marker in stage I–III colorectal cancer. International Journal of Cancer 2015; 137(9): 2104 doi: 10.1002/ijc.29596
|
| 94 |
Alhadi Almangush, Markku Karhunen, Sampsa Hautaniemi, Tuula Salo, Ilmo Leivo. Prognostic value of tumour budding in oesophageal cancer: a meta‐analysis. Histopathology 2016; 68(2): 173 doi: 10.1111/his.12781
|